Variation in Routine Use of a 60 to 63 Gy Intermediate Dose Clinical Target Volume With Primary Radiation therapy for Mucosal Squamous Cell Carcinoma of the Head and Neck

被引：0
|
作者：
Freedman, Laura [1 ]
Galloway, Thomas [2 ]
Hu, Kenneth [3 ,4 ]
Mierzwa, Michelle [5 ]
机构：
[1] Univ Miami, Dept Radiat Oncol, Miami, FL 33146 USA
[2] Temple Univ Hlth Syst, Fox Chase Canc Ctr, Philadelphia, PA USA
[3] NYU Langone Med Ctr, Dept Radiat Oncol, New York, NY USA
[4] NYU Langone Med Ctr, Dept Otolaryngol, New York, NY USA
[5] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI USA
来源：
PRACTICAL RADIATION ONCOLOGY | 2022年 / 12卷 / 05期
关键词：
D O I：
10.1016/j.prro.2022.03.010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E393 / E396
页数：4
相关论文
共 50 条
  • [31] A phase III study of high dose radiation therapy with or without cetuximab in patients with locoregionally advanced squamous cell carcinoma of the head and neck
    Giralt, J
    Haran, PM
    Ang, KK
    Azarnia, N
    Cohen, RB
    Kies, MS
    Jassem, J
    Harstick, A
    Baselga, J
    Bonner, JA
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S127 - S127
  • [32] Correlating Clinical Outcomes With Changes in Tumor Volume and 18F-FDG PET Characteristics During Radiation Therapy for Head and Neck Squamous Cell Carcinoma (HNSCC)
    Mowery, Y. M.
    Vergalasova, I.
    Yoo, D. S.
    Das, S. K.
    Hara, W.
    Brizel, D. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (04): : 920 - 920
  • [33] Recurrence Pattern of Squamous Cell Carcinoma in the Middle Thoracic Esophagus: Implications for the Clinical Target Volume Design of Postoperative Radiation Therapy
    Wang, X.
    Luo, Y.
    Fan, T.
    Yu, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E166 - E167
  • [34] Patterns of Failure after Intensity-modulated Radiotherapy in Head and Neck Squamous Cell Carcinoma using Compartmental Clinical Target Volume Delineation
    Bayman, E.
    Prestwich, R. J. D.
    Speight, R.
    Aspin, L.
    Garratt, L.
    Wilson, S.
    Dyker, K. E.
    Sen, M.
    CLINICAL ONCOLOGY, 2014, 26 (10) : 636 - 642
  • [35] A Phase II Study Of Concomitant Hyperfractionated Radiation Therapy And Double Dose Intra-Arterial Cisplatin For Squamous Cell Carcinoma Of The Head And Neck
    Regine, William F.
    Valentino, Joseph
    Arnold, Susanne M.
    Sloan, David
    Kenady, Daniel
    Strottmann, James
    Mohiuddin, Mohammed
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2002, 1 (02) : 133 - 140
  • [36] A Deep Learning Model for Predicting Xerostomia Due to Radiation Therapy for Head and Neck Squamous Cell Carcinoma in the RTOG 0522 Clinical Trial
    Men, Kuo
    Geng, Huaizhi
    Zhong, Haoyu
    Fan, Yong
    Lin, Alexander
    Xiao, Ying
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (02): : 440 - 447
  • [37] Phase 1 Dose Escalation of Stereotactic Body Radiation Therapy and Concurrent Cisplatin for Reirradiation of Unresectable, Recurrent Squamous Cell Carcinoma of the Head and Neck
    Echevarria, Michelle I.
    Yang, George Q.
    Chen, Dung-Tsa
    Kirtane, Kedar
    Russell, Jeffery
    Kish, Julie
    Muzaffar, Jameel
    Otto, Kristen
    Padhya, Tapan
    Mcmullen, Caitlin
    Patel, Krupal
    Chung, Christine H.
    Caudell, Jimmy J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : 341 - 347
  • [38] The Impact of FDG-PET Imaging on the Clinical Management and Radiation Therapy Planning in Patients With Head-and-Neck Squamous Cell Carcinoma
    Waters, A.
    Sultanem, K.
    Bahoric, B.
    Hier, M.
    Deblois, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S509 - S510
  • [39] Radiation therapy with hyperbaric oxygen at 4 atmospheres pressure in the management of squamous cell carcinoma of the head and neck: Results of a randomized clinical trial
    Haffty, BG
    Hurley, R
    Peters, LJ
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1999, 5 (06): : 341 - 347
  • [40] The Influence of Smoking and Co-morbidity on Dose Achievement in Primary or Adjuvant Radio(Chemo)Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
    Fazel, Asita
    Quabius, Elgar Susanne
    Fabian, Alexander
    Schleicher, Thilo
    Kress, Konstantin
    Laudien, Martin
    Huber, Karen
    Herzog, Arved
    Donate, Mireia Gonzales
    Hoffmann, Markus
    FRONTIERS IN ONCOLOGY, 2020, 10
12345